T he culprit lesion in ST-segment-elevation myocardial infarction (STEMI) is usually occluded, thrombotic, and subject to vasospasm.
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Optical Coherence Tomography-Guided PCI in STEMI accurately evaluate stent underexpansion and malapposition even in the presence of plaque prolapse or thrombus. 9 In this study, we compared a prospective cohort of patients undergoing OCT guidance during STEMI with a propensity-matched cohort of patients undergoing angiography-guided PCI for STEMI enrolled in the Thrombectomy Versus PCI Alone (TOTAL) Trial.
Methods
All patients were enrolled in the TOTAL trial of aspiration thrombectomy versus PCI alone and detailed study methods were previously reported. 10 The trial included patients presenting with symptoms of myocardial ischemia lasting for ≥30 minutes, and definite ECG changes indicating STEMI (ST-elevation of >0.1 mV in 2 contiguous limb leads or 0.2 mV in 2 contiguous precordial leads) who were referred for primary PCI and randomized within 12 hours of symptom onset. Patients ≤18 years of age, previous coronary artery bypass surgery, life expectancy <6 months because of noncardiac condition, or treatment with fibrinolytic therapy for qualifying index STEMI event were excluded. In the OCT substudy, we prospectively enrolled 214 patients who underwent OCT guidance during PCI. OCT imaging was performed according to a prespecified protocol. This protocol provided criteria for image-guided optimization of the PCI procedure. In this substudy, patients were excluded if they had cardiogenic shock or known renal failure. The study was approved by the research ethics board at each participating center and all patients provided written informed consent. We performed a 2:1 propensity match to identify 428 patients within the TOTAL trial who underwent PCI with angiography guidance alone. All patients randomized in the TOTAL trial who had undergone PCI and who were not also enrolled in the OCT substudy were eligible for matching.
The propensity score was estimated using a logistic regression model with the following baseline characteristics as predictor variables: age (years), sex (male and female), Killip class (class 1, 2, 3, or 4), MI location (anterior or anterolateral, inferior or inferolateral, anterior and inferior, lateral alone, other), creatinine (µmol/L), diabetes mellitus, current smoking, previous MI, previous PCI, peripheral arterial disease, presentation heart rate, presentation blood pressure, symptom onset to hospital arrival, hospital arrival to first device, use of upfront glycoprotein IIb/IIIa inhibitors, region of enrollment (North America and outside North America), single-vessel disease versus multivessel disease, lesion location (left main, proximal left anterior descending, mid or distal left anterior descending, left circumflex, and right coronary artery), initial Thrombolysis in Myocardial Infarction (TIMI) thrombus grade (≥4 and <4), initial TIMI flow (≥2 and<2). The angiography-guided PCI group was selected on the logit of the propensity score with calipers of width equal to 0.2 of the SD of the logit of the estimated propensity score. 11, 12 To assess whether the propensity score model was adequate in balancing the baseline characteristics between the OCT and the angiography groups, standardized differences were calculated in the unmatched and matched samples. We accepted a standardized difference of <0.1 (ie, <10%) can be taken to indicate a negligible difference between 2 groups.
13

OCT-Guided PCI
In the OCT group, prestent imaging was performed after restoration of TIMI 2 or 3 flow (after thrombectomy or first balloon inflation, or before direct stenting) and after angiographic optimization of the stent result provided TIMI 2 or 3 flow was present. In prestent imaging, operators reviewed the OCT image results to assess the location of plaque rupture and lesion length to inform stent length selection. Measurements were performed to determine the proximal and distal reference diameters to inform stent size selection. Operators reported how often they incorporated these OCT findings into the selection of stent length and diameter. For poststent imaging, operators reviewed the OCT image results to evaluate stent expansion, apposition, and peristent pathology. Operators performed real-time interpretation of the OCT findings, and further interventional treatment was based on prespecified criteria for OCT-guided PCI optimization based on expert consensus and previous studies. Treatment of stent underexpansion was recommended if the minimum in-stent cross-sectional area was <90% compared with the mean of the proximal and distal reference segment as per intravascular ultrasound (IVUS) criteria.
14 Treatment of stent malapposition was suggested if there was stent malapposition of >300 µm and longer than 1000 µm provided the area was >1 mm from the stent edge. 15 For edge dissections, treatment was recommended if the dissection was visualized on angiography or if it was associated with OCT evidence of deeper vessel injury (development of intramural hematoma or penetration to the media). 16 Additional stenting was recommended for plaque rupture visualized outside the stented segment 17 or residual area stenosis >50% within 5 mm of the proximal and distal stent edges. The area stenosis was determined as 1 minus the lumen area of the stenosis divided by the lumen area of the reference segment proximal or distal to the stenosis. Any post-OCT interventions (postdilation using compliant or noncompliant balloons, additional stenting, or thrombectomy) were recorded.
Angiographic Analysis
Final angiographic images were recorded after removal of all intracoronary wires at 30 frames per second. Evaluation was performed in a dedicated core laboratory (Hamilton Health Sciences) using Medis QAngio XA software and blinded to the treatment group. Angiograms were evaluated for TIMI flow, TIMI thrombus burden, minimum lumen diameter (MLD), reference vessel diameter, and diameter stenosis at baseline and on the final poststent angiograms. Two orthogonal projections were evaluated wherever possible, and the lowest MLD was used. Patients treated without final stent implantation did not have postprocedure measurements performed. Angiographic complications were assessed.
Outcomes
The primary outcome was the composite of cardiovascular death, myocardial infarction, stent thrombosis, and target-vessel revascularization ≤1 year post randomization. The secondary outcomes were the individual components of the primary composite outcome, the final in-stent angiographic MLD, procedure time, total contrast dose, and percentage of patients with 70% resolution of ST-elevation in postindex PCI-ECG.
WHAT IS KNOWN
• Image-guided percutaneous coronary intervention (PCI) with intravascular ultrasound results in larger final poststent minimum lumen diameter compared with angiography-guided PCI.
• The role of optical coherence tomography guidance during primary PCI has not been previously evaluated.
WHAT THE STUDY ADDS
• Optical coherence tomography-guided primary PCI resulted in larger final poststent minimum lumen diameter compared with angiography-guided primary PCI.
• Optical coherence tomography guidance was associated with longer procedure times and higher contrast doses compared with angiography guidance.
• Future larger trials are needed to determine if optical coherence tomography guidance can improve clinical outcomes. Optical Coherence Tomography-Guided PCI in STEMI
Statistical Considerations
The evaluation of OCT-guided versus angiography-guided PCI was a prespecified objective of the OCT substudy. 18 For this analysis, we anticipated the 1-year event rate for death, myocardial infarction, stent thrombosis, and target-vessel revascularization would be 20% in the angiography group. On the basis of data from previous nonrandomized IVUS guidance studies, 19, 20 a 40% relative risk reduction with OCT guidance was anticipated. With 200 patients in the OCT group and 400 patients in the angiography group, the study would have 70% power to detect a 40% relative risk reduction in a 20% composite event rate. The primary outcome and the individual components of the primary outcome were analyzed as time-to-event variables. Cox proportional hazards regression models were used to compare event rates between the groups with OCT guidance (n=214) and angiographic guidance (n=428). We tested for interaction between the effect of OCT guidance versus angiographic guidance and the effect of thrombectomy versus PCI alone. Two-sided type I error level was set at 5%. If the interaction was not significant, both the main effect of thrombectomy versus PCI alone and the interaction were removed from the model. Other outcomes were compared using Wilcoxon 2-sample tests for continuous variables and Pearson χ 2 tests for categorical variables. Two-sided type I error level was set at 5%.
Results
The Table in the Data Supplement shows the baseline characteristics that were included in the propensity matching. Patients in the OCT group were more likely to have shorter time from symptom onset to hospital arrival, longer time from hospital arrival to first device, and more upfront glycoprotein IIb/IIIa use. They were more likely to have preprocedure TIMI 2 or greater flow and to be recruited from a North American center. These differences were no longer significant after the propensity match was performed.
The angiographic and procedural details are shown in Table 1 . There was no difference in the preprocedure MLD, reference vessel diameter, TIMI flow, and TIMI thrombus grade between groups. The OCT group has a larger nominal stent diameter implanted. The OCT group also had a higher rate of radial access and more frequent use of drug-eluting stents.
In the OCT-guided group, prestent OCT was performed in 199 (93.0%) patients. The reasons for not performing OCT were reocclusion or TIMI flow <2 after initial flow restoration (7 patients) and operator decision (8 patients). Prestent findings were incorporated in the procedure planning (choice of length or diameter) in 141 (65.9%) patients (Table 2) . Poststent OCT was performed in 206 (96.2%) patients. The reasons for not performing poststent OCT were operator decision (7 patients) or TIMI flow <2 (1 patient). OCT findings of significant edge dissection, stent malapposition, stent underexpansion, and significant residual disease led to further balloon dilation, stenting, or thrombectomy in 89 (42.5%) patients.
The final in-stent MLD was 2.99±0.48 mm in the OCTguided group versus 2.79±0.47 mm in the angiography-guided group (P<0.0001; Table 3 ). The cumulative frequency distribution of baseline and final MLD are shown in the Figure. Final procedure TIMI flow, no reflow, and other angiographic complications were not different between groups. Resolution in ST-segment-elevation of at least 70% was seen in a similar proportion in both groups. OCT-and angiography-guided PCI had a median (interquartile range) procedure time of At 1 year, the primary outcome of cardiovascular death, myocardial infarction, stent thrombosis, and target-vessel revascularization was seen in 16 (7.5%) patients in the OCTguided group versus 42 patients (9.8%) in the angiographyguided group (HR, 0.76; 95% CI, 0.43-1.34; P=0.34; Table 4 ). None of individual primary end point components reached statistical significance. There was no interaction between the effect of OCT guidance versus angiography guidance and randomization to thrombectomy or PCI alone.
Discussion
We conducted a prospective, propensity-matched cohort study of OCT-guided versus angiography-guided PCI and demonstrated that OCT guidance frequently alters PCI management in STEMI patients, resulting in a larger final in-stent MLD, longer procedure time, and higher contrast dose compared with angiography guidance. No statistically significant difference in clinical outcomes was observed at 1 year.
In our study, OCT imaging was performed both before and after stent implantation. Prestent imaging by OCT may clarify the location of the culprit lesion, site of thrombosis. or plaque rupture, and the longitudinal extent of disease in the vessel.
Prestent image findings were incorporated in stent selection in 65.9% of patients, a frequency that was similar to the 57% of patients who had prestent management change based on OCT in the Ilumien I study. 21 OCT imaging after stenting can distinguish between stent underexpansion and plaque prolapse, both of which may narrow the lumen on angiography. Our threshold for stent underexpansion was based on previous IVUS criteria. 14 OCT is more sensitive for the detection of malapposition compared with IVUS. 15 Our protocol suggested treatment of malapposition that was >300 μm from the stent strut to the vessel interface because less severe malapposition will almost always resolve at late follow-up. 15 For stent edge dissections, we intervened on deep or angiographically evident dissections, given that most dissections identified by OCT are small and resolve without clinical sequela. 16 The frequency of additional interventions after OCT imaging (42.5%) was similar in our study to the rate reported by the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention investigators (34.7%). 9 When the TOTAL OCT study protocol was developed, prospective data to inform the selection of thresholds for intervention based on OCT findings were not available. We based our criteria for intervention on expert consensus and extrapolation from studies using IVUS. Recently, observational studies have reported outcomes associated with poststent OCT findings. 22, 23 These studies identified poststent minimum stent area and stent edge disease as predictors of adverse outcome at follow-up. Malapposition and proximal edge dissection were not predictors of adverse outcome, and there were conflicting results about tissue protrusion and distal edge dissection. These results should be considered in the design of future OCT-guided intervention studies. In our study, to obtain the OCT information, operators spent an average of 20 minutes more per procedure and used an average of 46 mL of additional contrast compared with angiography alone. Whether the additional time and contrast is worthwhile depends on the impact of OCT image guidance on outcomes.
The final angiographic in-stent MLD is a surrogate marker for improved long-term outcomes in imaged guided PCI. 24 Similarly, minimum stent area by OCT is a predictor of late outcomes, particularly target-vessel revascularization. 22 Recent meta-analyses of mostly observational studies demonstrate that IVUS guidance is associated with an improvement in MLD of 0.12 mm. 24 However, it remains controversial Interactions with the effect of thrombectomy vs percutaneous coronary intervention alone were not significant for all outcomes. CI indicates confidence interval; and OCT, optical coherence tomography.
*Cox proportional hazards regression model for the effect of OCT guidance vs angiography guidance.
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http://circinterventions.ahajournals.org/ Downloaded from whether OCT can achieve similar improvements in stent expansion. 25 A previous study suggested that OCT may underestimate stent dimensions and lead to smaller stent sizing compared with IVUS. 26 In contrast, we have demonstrated that OCT guidance can achieve significant improvement in the MLD compared with angiography. This improvement was associated with a larger reference vessel diameter poststenting in the OCT group, despite no difference in reference vessel diameter at baseline. This is probably because of selection of larger stents and frequent use of postdilation in the OCT group. The magnitude of improvement (0.20 mm) is similar to the largest differences observed in previous IVUS studies. 24 Although only patients with STEMI were included, the increase in stent expansion with OCT guidance was not associated with reduced final angiographic flow or an increase in angiographic complications.
We did not observe a significant reduction in clinical events with OCT guidance at 1 year. There were substantially fewer events in the angiography-guided group than anticipated and the observed 24% risk reduction with OCT was lower than anticipated. Therefore, the study was underpowered to detect a statistical difference in clinical outcomes. However, the findings are hypothesis generating and suggest that OCT, such as IVUS, has the potential to improve clinical outcomes in patients undergoing PCI. Both our study and previous IVUS studies, which are mostly observational, are subject to potential confounding because of lack of randomization. Therefore, the data need to be cautiously interpreted. Given the observed 9.6% event rate in the angiography group and estimated risk reduction of 24%, >2700 patients would need to be included in a randomized trial of adequate power to detect a difference in clinical outcomes with OCT guidance.
Limitations
We conducted a propensity match on baseline and preprocedural variables. Although the match was successful in eliminating differences between the groups on all identified variables, several procedural factors, particularly, the rate of radial access and the frequency of drug-eluting stent use, differed between groups. These procedural factors were at the discretion of the local operators and not likely related to the use of OCT versus angiography alone. Recruitment for the OCT substudy was conducted in a subgroup of the centers participating in the TOTAL trial; therefore, these differences may reflect variations in local practice. In addition, there may be other unrecognized confounders that could not be addressed through propensity matching. Final OCT evaluation was not required by the study protocol and only performed at the discretion of the operators. Because we did not repeat blinded OCT runs at the conclusion of the procedure, we could not document if the abnormal findings were actually corrected by the operators.
Conclusions
OCT-guided PCI in STEMI frequently altered PCI management and was associated with a larger final in-stent MLD, longer procedure time, and higher contrast dose. There was no significant difference in clinical outcomes at 1 year; however, the study was underpowered to detect a treatment effect on this end point. Large randomized trials are required to determine if OCT guidance can improve clinical outcomes.
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